Rosalind Advisors’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.32M Buy
+2,400,000
New +$9.35M 2.35% 13

Other funds holding TARA

Rosalind Advisors's TARA Position: Q3 2026 in Review

Rosalind Advisors opened a new position in Protara Therapeutics (TARA) in Q3 2026: 2,400,000 shares worth $7.32M. The stake represents 2.35% of the portfolio and ranks #13 among its holdings.

119 funds tracked by Wall St. Rank hold TARA as of Q3 2026.

  • Rosalind Advisors held 2,400,000 shares of Protara Therapeutics worth $7.32M as of Q3 2026.
  • Protara Therapeutics was a new Rosalind Advisors position in Q3 2026.
  • Protara Therapeutics made up 2.35% of Rosalind Advisors's portfolio in Q3 2026, its #13 holding.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.

Based on Rosalind Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.